Nexus AG's EBIT per Share for the
three
months ended in Sep. 2025 was €0.60.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was €2.69.
During the past 12 months, the average EBIT per Share Growth Rate of Nexus AG was 16.20% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 13.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 20.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 15.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nexus AG's EBIT per Share or its related term are showing as below:
LTS:0FGL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -44.9 Med: 17.6 Max: 101
Current: 13.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Nexus AG was 101.00% per year. The lowest was -44.90% per year. And the median was 17.60% per year.
LTS:0FGL's 3-Year EBIT Growth Rate is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 11.8
vs LTS:0FGL: 13.60
Nexus AG's EBIT for the
three
months ended in Sep. 2025 was €10.4 Mil.
Nexus AG (LTS:0FGL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nexus AG EBIT per Share Related Terms
Nexus AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nexus AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexus AG (LTS:0FGL) has a EBIT per Share of €2.69 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nexus AG and its competitors.
Is Nexus AG's EBIT per Share too high?
Nexus AG's current EBIT per Share is €2.69. Overall, Nexus AG has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Nexus AG's EBIT per Share compare to VEEV and GEHC?
Nexus AG's EBIT per Share of €2.69 can be compared against companies in the Healthcare Providers & Services industry. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nexus AG and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus AG's current EBIT per Share is €2.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus AG stock overvalued right now?
Nexus AG (LTS:0FGL) has a current EBIT per Share of €2.69. The stock's GF Value™ is €74.59, compared to a current price of €71.70 — trading 3.9% below its estimated fair value. The current EBIT per Share is €2.69. Nexus AG's overall GF Score™ is 11/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nexus AG (LTS:0FGL), the current EBIT per Share is €2.69 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus AG (LTS:0FGL) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus AG stock appears to be undervalued.
The current stock price of €71.70 is trading 3.9% below its estimated GF Value™ of €74.59.
Key valuation signals for LTS:0FGL:
EBIT per Share: €2.69
GF Value™: €74.59 vs. price of €71.70 (3.9% below fair value)
No single metric tells the full story. See the LTS:0FGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations especially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
11GF Score
Get the complete analysis for LTS:0FGL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0FGL has been successfully added to your 
